Adverse reactions during peanut oral immunotherapy home dosing

 Disclosure of potential conflict of interest: P. Varshney received the National Institutes of Health T32 Training Grant. B. P. Vickery has received research support from the Thrasher Research Foundation. J. A. Bird has received research support from the Food Allergy Initiative. A. M. Scurlock has received research support from the National Institutes of Health. T. T. Perry has received research support from the National Institutes of Health and the Robert Wood Johnson Foundation. S. M. Jones is a consultant for and board member of the Food Allergy & Anaphylaxis Network and has received research support from the National Institutes of Health and DYAX Corporation. A. W. Burks is a Consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, and Novartis; is a minority stockholder of Allertein and MastCell, Inc; is on the Advisory Board for Dannon Co. Probiotics; is on the Expert Panel for Nutricia; has received research support from the National Institutes of Health, the Food Allergy & Anaphylaxis Network, and the Wallace Research Foundation; has served as an expert witness on the topic of food allergies; is on the Medical Board of Directors for the Food Allergy & Anaphylaxis Network and the Dermatological Allergy Committee for the American College of Allergy, Asthma & Immunology; is a member for the National Institutes of Health Hypersensitivity, Autoimmune and Immune-mediated Disease Study Section; and is on the Journal of Allergy and Clinical Immunology reviewer board. The rest of the authors have declared they have no conflict of interest.